Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
44.5M
-
Number of holders
-
67
-
Total 13F shares, excl. options
-
19.9M
-
Shares change
-
-804K
-
Total reported value, excl. options
-
$93.4M
-
Value change
-
-$6.73M
-
Put/Call ratio
-
0.14
-
Number of buys
-
38
-
Number of sells
-
-36
-
Price
-
$4.70
Significant Holders of TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) as of Q2 2024
83 filings reported holding TELA - TELA Bio, Inc. - Common Stock, par value $0.001 per share as of Q2 2024.
TELA Bio, Inc. - Common Stock, par value $0.001 per share (TELA) has 67 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.9M shares
of 44.5M outstanding shares and own 44.63% of the company stock.
Largest 10 shareholders include Essex Woodlands Management, Inc. (4.11M shares), ORBIMED ADVISORS LLC (2.46M shares), Nantahala Capital Management, LLC (2.45M shares), AIGH Capital Management LLC (1.66M shares), PARADIGM CAPITAL MANAGEMENT INC/NY (1.26M shares), SILVERARC CAPITAL MANAGEMENT, LLC (1M shares), VANGUARD GROUP INC (904K shares), Velan Capital Investment Management LP (746K shares), FEDERATED HERMES, INC. (712K shares), and Stonepine Capital Management, LLC (626K shares).
This table shows the top 67 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.